Psychemedics Corporation
PMDI
$2.30
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -11.16% | -11.98% | -12.18% | -12.45% | -12.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.16% | -11.98% | -12.18% | -12.45% | -12.20% |
| Cost of Revenue | -12.08% | -12.25% | -14.61% | -14.19% | -15.17% |
| Gross Profit | -9.65% | -11.52% | -8.02% | -9.46% | -6.82% |
| SG&A Expenses | 0.18% | 11.02% | 9.44% | 12.60% | 2.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.03% | -4.20% | -6.25% | -4.96% | -8.87% |
| Operating Income | -21.64% | -105.31% | -84.82% | -169.62% | -42.32% |
| Income Before Tax | -0.96% | -56.95% | -113.44% | -230.58% | -6.91% |
| Income Tax Expenses | -95.58% | 462.62% | 904.10% | 1,527.27% | 235.52% |
| Earnings from Continuing Operations | 23.15% | -140.58% | -195.82% | -283.21% | -93.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.15% | -140.58% | -195.82% | -283.21% | -93.21% |
| EBIT | -21.64% | -105.31% | -84.82% | -169.62% | -42.32% |
| EBITDA | -128.05% | -4,492.16% | -685.35% | -249.04% | -365.92% |
| EPS Basic | 24.45% | -136.55% | -190.31% | -276.49% | -88.35% |
| Normalized Basic EPS | -19.18% | -98.50% | -78.40% | -176.48% | -42.80% |
| EPS Diluted | 24.45% | -134.58% | -187.29% | -271.07% | -86.90% |
| Normalized Diluted EPS | -19.18% | -98.50% | -78.40% | -176.24% | -42.73% |
| Average Basic Shares Outstanding | 2.21% | 2.12% | 2.14% | 2.03% | 1.83% |
| Average Diluted Shares Outstanding | 2.21% | 2.12% | 2.14% | 1.78% | 1.58% |
| Dividend Per Share | -100.00% | -100.00% | -100.00% | -75.00% | -46.15% |
| Payout Ratio | 1.00% | 1.00% | 0.77% | 0.82% | 0.42% |
